LianBio
LIANY- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001831283
No open-market purchases or sales by LianBio insiders were filed in the last 90 days; 1 institution reported holding it in 13F filings for Q2 2026, worth $1.00K in total; no superinvestor holds it.
Key figures
- Insider buysOpen market, last 90 days
- 0
- Insider sellsOpen market, last 90 days
- 0
- 13F holdersQ2 2026, 0 vs. previous quarter
- 1
- 13F valueReported value at the end of Q2 2026
- $1.00K
- Superinvestors holdingAt the end of Q2 2026
- 0
Price chart
Superinvestors holding LIANY, Q2 2026
No superinvestor reported holding LIANY at the end of Q2 2026.
Latest insider trades
Open-market purchases and sales by LianBio insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Apr 11, 2024 (view filing)4:10 PM ET | Jan 2 | 100 daysLate | Gu EhongInterim CFO | SSale | −1.73K | $4.34 | −$7.51K | −2.2%76.8K after | |
| Jan 5, 2023 (view filing) | Jan 3 | 2 days | Qian JiangSVP, China General Manager | SSale | −2.24K | $1.65 | −$3.69K | −3.2%67.3K after | |
| Aug 22, 2022 (view filing)9:17 AM ET | Aug 18 | 4 days | Edelman Joseph and 7 othersDirector, 10% Owner | PPurchaseAmerican Depositary Shares | +998.2K | $2.40 | +$2.40M | +36.6%3.73M after | |
| May 27, 2022 (view filing)10:06 AM ET | May 26 | 1 day | Edelman Joseph and 7 othersDirector, 10% Owner | PPurchaseAmerican Depositary Shares | +69.0K | $3.13 | +$216.0K | +2.6%2.73M after | |
| May 25, 2022 (view filing)6:51 PM ET | May 23-25 | 2 days | Edelman Joseph and 7 othersDirector, 10% Owner | PPurchaseAmerican Depositary Shares | +171.3K | $2.58 | +$442.4K | +6.9%2.66M after | 3 lots |
| Nov 5, 2021 (view filing)1:47 PM ET | Nov 3 | 2 days | Edelman Joseph and 7 othersDirector, 10% Owner | PPurchase | +2.27M | $15.98 | +$36.3M | +8.9%27.9M after | 2 lots |
| Nov 3, 2021 (view filing)6:59 PM ET | Nov 1-2 | 2 days | Perceptive Advisors LLC and 7 othersDirector, 10% Owner | PPurchase | +220.0K | $14.59 | +$3.21M | +3.1%7.25M after | 2 lots |
Top 10 13F holders, Q2 2026
The largest institutional positions in LianBio at the end of Q2 2026; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| FNY Investment Advisers, LLC | 14,000 | $1.00K | 0.00% | 00.0% | Unchanged |